-Reuters
Reported Earlier, Emergent BioSolutions Announces Preliminary 2022 Financial Results; Sees FY22 Revenue Of $1.1B-$1.12B Vs Prior Guidance Of $1.05B-$1.1B
PRELIMINARY 2022 FINANCIAL RESULTS (Unaudited)
The company is providing the following selected preliminary, unaudited financial results for full-year 2022.